Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel
Apollo Green₹ 72 (28.6%)ASK Investment₹ 895 (-3.2%)AVPL ₹ 49 (0%)Bootes Impex₹ 775 (-8.8%)CIAL ₹ 442 (-0.5%)CSK ₹ 254 (-3.1%)ESDS Software₹ 478 (2.8%)Garuda Aerospace₹ 468 (-2.1%)Goodluck Defence₹ 385 (16%)Hero Motors₹ 325 (0%)Hinduja Leyland₹ 248 (0%)ICL Fincorp₹ 25 (0%)Incred Holdings₹ 154 (2.7%)Kineco Limited₹ 3285 (0%)Lava ₹ 60 (15.4%)Market Simplified₹ 26 (-7.1%)Matrix Gas₹ 12 (-20%)Motilal Oswal₹ 12.25 (-2%)MSEI ₹ 6.35 (-2.3%)NCDEX ₹ 368 (-1.6%)NSE ₹ 1985 (-2%)Onix Renewable₹ 68 (21.4%)OYO ₹ 23 (-4.2%)OYO Assets₹ 9.25 (-7%)Philips India₹ 1250 (0%)Polymatech Electronics₹ 56 (-3.4%)SBI Mutual₹ 768 (-0.9%)Taparia Tools₹ 6050 (0%)VCI Chemical₹ 64 (0%)Zepto ₹ 40 (-4.8%)

15 Days Price Change

Nephro Care India IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds
Profile
Issue Size --
Profile
Price Range 85  to  90 per share
Profile
Min Investment ₹90
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus --
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Nephro Care India Ltd is a healthcare provider that specializes in the treatment of kidney-related diseases. Our team of experienced nephrologists and healthcare professionals are dedicated to providing our patients with the highest quality care and treatment. At Nephro Care India Ltd, we understand the challenges that come with managing kidney-related diseases. That’s why we offer holistic treatment plans tailored to meet the unique needs of each patient. Our state-of-the-art facilities are equipped with the latest technology and equipment to ensure that our patients receive the best care possible. Our mission at Nephro Care India Ltd is to improve the quality of life for our patients by providing them with the care and support they need to manage their kidney-related diseases.We are committed to providing compassionate care and treating our patients with the respect and dignity they deserve. At Nephro Care India Ltd, our patients come first, and we strive to ensure that every patient receives the care they need to live a healthy and fulfilling life. Read More

Basic Info

Face Value 10 per share

Price 85  to  90 per share

P/E (x) 37.5

Sales( Cr.) 46

PAT( Cr.) 4

EPS 2.4

Draft Prospectus --

Exchange NSE-SME

Promoter

Company Promoters

Dr. Pratim Sengupta

Pre Issue Share Holding 85.02%

Post Issue Share Holding --%

Listing Details:

Listing Price: 171

Listing Gain: 47.37%

Current Price: 76.3

Gain On Issue: 76.3 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Jun 28, 2024
Closing Date Jul 02, 2024
Allotment Jul 03, 2024
Refund Jul 04, 2024
Delivery of Shares Jul 04, 2024
Listing Date Jul 05, 2024

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 1600 144,000
Retail (Max) 1 1600 144,000
S-HNI (Min) 2 3200 288,000
S-HNI (Max) 6 9600 864,000
B-HNI (Min) 7 11200 1,008,000

Objective of the Issue

1. Setting up of Multi Speciality Hospital in the name of Vivacity Multi Specialty Hospital (unit of Nephro Care) at Kolkata (Madhyamgaram), West Bengal 2. General Corporate Expenses

Issue

Category Nos Bid Bid (x)
QIB 2292000 561860880 245.1x
NII 687600 1228871844 1787.2x
Retail 1604400 1017382128 634.1x
EMP 0 0 0x
Total 4584000 3281135520 715.8x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Nephro Care India Profit & Loss

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 2 3 17 27 46
Other Income 0 0 0 0 2
Total Income 2 3 17 28 48
Total Expenditure 2 3 14 21 40
Operating Profit 0 0 3 7 7
Interest 0 0 0 0 0
Depreciation 0 0 1 1 2
Exceptional Income / Expenses 0 0 0 0 0
Profit Before Tax 0 0 3 6 5
Provision for Tax 0 0 0 2 1
Profit After Tax 0 -0 2 5 4
Adjustments 0 0 0 -0 0
Profit After Adjustments 0 -0 2 4 4
Adjusted Earnings Per Share 4.4 -0 2.4 3.8 2.2

Nephro Care India Balance Sheet

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 0 0 3 15 53
Minority's Interest 0 0 0 0 0
Borrowings 1 2 2 0 0
Other Non-Current Liabilities 0 0 -0 -0 1
Total Current Liabilities 0 2 3 6 14
Total Liabilities 1 5 8 21 68
Fixed Assets 0 1 3 5 31
Other Non-Current Assets 1 2 2 5 9
Total Current Assets 1 1 3 11 28
Total Assets 1 5 8 21 68

Nephro Care India Cash Flow

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 1 2 1
Cash Flow from Operating Activities 0 1 4 1 8
Cash Flow from Investing Activities -0 -3 -2 -8 -40
Cash Flow from Financing Activities 0 2 -0 6 35
Net Cash Inflow / Outflow 0 0 2 -1 3
Closing Cash & Cash Equivalent 0 1 2 1 5

Nephro Care India Ratios

# Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 4.44 -0.01 2.37 3.78 2.21
CEPS(Rs) 5.09 0.1 3.16 4.23 3.7
DPS(Rs) 0 0 0 0 0
Book NAV/Share(Rs) 0.75 0.5 2.53 12.62 32.44
Core EBITDA Margin(%) 8.47 3.67 20.04 23.75 12.76
EBIT Margin(%) 8.19 0.49 15.46 23.17 10.73
Pre Tax Margin(%) 6.46 0.01 15.08 22.85 10.49
PAT Margin (%) 4.86 -0.29 13.88 16.53 7.91
Cash Profit Margin (%) 5.57 2.97 18.47 18.47 13.25
ROA(%) 7.88 -0.34 37.08 31 8.16
ROE(%) 591.33 -3.84 156.92 51.3 10.62
ROCE(%) 21.11 0.9 65.72 62.97 14.42
Receivable days 0 20.54 2.52 1.32 13.4
Inventory Days 5.04 10.44 6.99 5.61 6.26
Payable days 94.24 96.02 51.44 56.5 79.79
PER(x) 0 0 0 0 57.61
Price/Book(x) 0 0 0 0 3.92
Dividend Yield(%) 0 0 0 0 0
EV/Net Sales(x) 0.12 0.71 0.04 0.39 4.45
EV/Core EBITDA(x) 1.36 18.94 0.19 1.55 27.7
Net Sales Growth(%) 0 87.66 399.14 59.31 69.04
EBIT Growth(%) 0 -88.76 0 138.7 -21.7
PAT Growth(%) 0 -111.05 0 89.77 -19.18
EPS Growth(%) 0 -100.22 0 59.44 -41.65
Debt/Equity(x) 46.18 5.12 0.98 0 0
Current Ratio(x) 1.08 0.66 0.89 1.86 2.01
Quick Ratio(x) 1.03 0.55 0.75 1.8 1.93
Interest Cover(x) 4.74 1.01 40.23 74.13 44.86
Total Debt/Mcap(x) 0 0 0 0 0

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 70% 148% 0% 0%
Operating Profit CAGR 0% 0% 0% 0%
PAT CAGR -20% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -44% NA% NA% NA%
ROE Average 11% 73% 161% 161%
ROCE Average 14% 48% 33% 33%

Company Contact Information

Nephro Care India Ltd.

Flat No-1 J C-18, 5th Floor Sec- I I I Bidhan Nagar Sai Complex Salt Lake

IPO Lead Manager(s)

Nephro Care India Ltd.

Corporate Capital Ventures Pvt Ltd.

Registrar Info

Nephro Care India Ltd.

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp

Error!